BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6151957)

  • 1. The metyrapone test in affective disorders and schizophrenia II. Changes upon treatment.
    Perini GI; Fava GA; Morphy MA; Carson SW; Molnar G; Jusko WJ
    J Affect Disord; 1984 Dec; 7(3-4):265-72. PubMed ID: 6151957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metyrapone test in affective disorders and schizophrenia.
    Fava GA; Carson SW; Perini GI; Morphy MA; Molnar G; Jusko WJ
    J Affect Disord; 1984 Jun; 6(3-4):241-7. PubMed ID: 6235255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression and metyrapone tests in depression.
    Morphy MA; Fava GA; Perini GI; Molnar G; Zielezny M; Lisansky J
    Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metyrapone test in manic patients and healthy subjects.
    Perini GI; Fava GA; Morphy MA; Carson SW; Molnar G; Jusko WJ
    Pharmacopsychiatry; 1984 May; 17(3):94-7. PubMed ID: 6739539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of in-patient and out-patient prescribing.
    Anderson DN
    Br J Psychiatry; 1989 May; 154():644-9. PubMed ID: 2574606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet monoamine oxidase activity and behavioral response to pharmacotherapy in psychiatric patients.
    Rosen AJ; Wirtshafter D; Pandey GN; Davis JM
    Psychiatry Res; 1982 Feb; 6(1):49-59. PubMed ID: 6120529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous analysis of cortexolone and cortisol by high-performance liquid chromatography for use in the metyrapone test.
    Carson SW; Jusko WJ
    J Chromatogr; 1984 Mar; 306():345-50. PubMed ID: 6715472
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs for psychiatric disorders.
    Treat Guidel Med Lett; 2013 Jun; 11(130):53-64; quiz 2p following 64. PubMed ID: 23715100
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacology and Leonhard's classification of endogenous psychoses.
    Ban TA
    Psychopathology; 1990; 23(4-6):331-8. PubMed ID: 1982184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs.
    Maes M; Delange J; Ranjan R; Meltzer HY; Desnyder R; Cooremans W; Scharpé S
    Psychiatry Res; 1997 Jan; 66(1):1-11. PubMed ID: 9061799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortisol changes in long-term lithium therapy.
    Smigan L; Perris C
    Neuropsychobiology; 1984; 11(4):219-23. PubMed ID: 6436729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective comparative study of interaction between lithium and modified electroconvulsive therapy.
    Thirthalli J; Harish T; Gangadhar BN
    World J Biol Psychiatry; 2011 Mar; 12(2):149-55. PubMed ID: 20645670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of personality factors on the success of psychopharmacotherapy].
    Rüger U
    Psychiatr Prax; 1985 Jan; 12(1):5-7. PubMed ID: 2858900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1989 Feb; 31(786):13-20. PubMed ID: 2563894
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of schizoaffective disorders.
    Goodnick PJ; Meltzer HY
    Schizophr Bull; 1984; 10(1):30-48. PubMed ID: 6142525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic function in the affective disorders: the effect of antidepressants and lithium on the 5-hydroxytryptophan-induced increase in serum cortisol.
    Meltzer HY
    Ann N Y Acad Sci; 1984; 430():115-37. PubMed ID: 6378031
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of carbamazepine as an adjunctive medication in the treatment of affective disorders: a clinical report.
    Kwamie Y; Persad E; Stancer H
    Can J Psychiatry; 1984 Nov; 29(7):605-8. PubMed ID: 6150757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs.
    Maes M; De Meester I; Scharpe S; Desnyder R; Ranjan R; Meltzer HY
    Acta Psychiatr Scand; 1996 Jan; 93(1):1-8. PubMed ID: 8919323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method for prediction of serum lithium levels.
    Alda M
    Biol Psychiatry; 1988 Jun; 24(2):218-24. PubMed ID: 3134057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.